2BB score and signals
MiNK Therapeutics, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 14 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 15 | Very Weak |
| Quality | 40 | Normal |
| Risk | 51 | Moderate |
Company facts
| CEO | lists 6,938 shares for sale at MiNK Therapeutics (Nasdaq: INKT) following stock award vesting. |
| Founded | 2017 |
| Employees | 15 |
| 52-week range | $8.48 – $16.93 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-29 | — | -0.3978 | — | $1.84M |
| 2026-11-12 | — | -0.357 | — | $1.63M |
| 2026-08-13 | — | -0.612 | — | $0.00 |
| 2026-05-15 | -0.57 | -0.7854 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish